title: The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review.
authors.affiliation: Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK.
authors.forename: J
authors.initials: J
authors.lastname: Dinnes
authors.forename: C
authors.initials: C
authors.lastname: Cave
authors.forename: S
authors.initials: S
authors.lastname: Huang
authors.forename: K
authors.initials: K
authors.lastname: Major
authors.forename: R
authors.initials: R
authors.lastname: Milne
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D003362:Cost-Benefit Analysis; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005910:Glioma / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D006801:Humans; D012008:Recurrence; D000077204:Temozolomide; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide